{"id":79346,"date":"2026-05-13T09:09:39","date_gmt":"2026-05-13T02:09:39","guid":{"rendered":"https:\/\/hbbgroup.net\/nhieu-lanh-dao-imexpharm-ban-co-phieu-trong-cung-mot-phien\/"},"modified":"2026-05-13T09:09:39","modified_gmt":"2026-05-13T02:09:39","slug":"nhieu-lanh-dao-imexpharm-ban-co-phieu-trong-cung-mot-phien","status":"publish","type":"post","link":"https:\/\/hbbgroup.net\/zh\/nhieu-lanh-dao-imexpharm-ban-co-phieu-trong-cung-mot-phien\/","title":{"rendered":"Nhi\u1ec1u l\u00e3nh \u0111\u1ea1o Imexpharm b\u00e1n c\u1ed5 phi\u1ebfu trong c\u00f9ng m\u1ed9t phi\u00ean"},"content":{"rendered":"<div data-role=\"content\" id=\"mainContent\">\n<p>Nhi\u1ec1u l\u00e3nh \u0111\u1ea1o c\u1ee7a C\u00f4ng ty c\u1ed5 ph\u1ea7n D\u01b0\u1ee3c ph\u1ea9m Imexpharm (IMP, s\u00e0n HoSE) v\u1eeba b\u00e1o c\u00e1o k\u1ebft qu\u1ea3 b\u00e1n ra c\u1ed5 phi\u1ebfu.<\/p>\n<p>Trong \u0111\u00f3, b\u00e0 Tr\u1ea7n Th\u1ecb \u0110\u00e0o &#8211; Th\u00e0nh vi\u00ean H\u0110QT ki\u00eam T\u1ed5ng Gi\u00e1m \u0111\u1ed1c Imexpharm, b\u00e1o c\u00e1o \u0111\u00e3 b\u00e1n 371.400 c\u1ed5 phi\u1ebfu IMP b\u1eb1ng ph\u01b0\u01a1ng th\u1ee9c th\u1ecfa thu\u1eadn trong phi\u00ean 7\/5. Sau giao d\u1ecbch, b\u00e0 \u0110\u00e0o h\u1ea1 t\u1ef7 l\u1ec7 s\u1edf h\u1eefu t\u1ea1i Imexpharm t\u1eeb 671.400 c\u1ed5 phi\u1ebfu (t\u1ef7 l\u1ec7 0,44% v\u1ed1n \u0111i\u1ec1u l\u1ec7) xu\u1ed1ng c\u00f2n 300.000 c\u1ed5 phi\u1ebfu (t\u1ef7 l\u1ec7 0,2%).<\/p>\n<figure type=\"Photo\">\n<p><img decoding=\"async\" data-author id=\"img_222390372796084224\" w=\"640\" h=\"426\" alt=\"Nhi\u1ec1u l\u00e3nh \u0111\u1ea1o Imexpharm b\u00e1n c\u1ed5 phi\u1ebfu trong c\u00f9ng m\u1ed9t phi\u00ean - \u1ea2nh 1.\" title rel=\"lightbox\" photoid=\"222390372796084224\" src=\"https:\/\/cafefcdn.com\/203337114487263232\/2026\/5\/13\/imp-17785751923031666615116-1778631691061-1778631691413265420365.jpg\" type=\"photo\" loading=\"lazy\" class width height><\/p><figcaption><\/figcaption><\/figure>\n<p>T\u01b0\u01a1ng t\u1ef1, \u00f4ng Ng\u00f4 Minh Tu\u1ea5n \u2013 Ph\u00f3 T\u1ed5ng Gi\u00e1m \u0111\u1ed1c Imexphar b\u00e1o c\u00e1o \u0111\u00e3 b\u00e1n 156.000 c\u1ed5 phi\u1ebfu IMP b\u1eb1ng ph\u01b0\u01a1ng th\u1ee9c th\u1ecfa thu\u1eadn c\u0169ng trong phi\u00ean 7\/5, qua \u0111\u00f3 gi\u1ea3m s\u1edf h\u1eefu v\u1ec1 c\u00f2n 150.000 c\u1ed5 phi\u1ebfu, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng kho\u1ea3ng 0,1% v\u1ed1n \u0111i\u1ec1u l\u1ec7.<\/p>\n<p>C\u0169ng trong phi\u00ean 7\/5, m\u1ed9t Ph\u00f3 T\u1ed5ng Gi\u00e1m \u0111\u1ed1c kh\u00e1c c\u1ee7a Imexpharm l\u00e0 \u00f4ng Hu\u1ef3nh V\u0103n Nhung \u0111\u00e3 b\u00e1n th\u1ecfa thu\u1eadn 80.000 c\u1ed5 phi\u1ebfu IMP, qua \u0111\u00f3 gi\u1ea3m s\u1edf h\u1eefu xu\u1ed1ng 100.000 c\u1ed5 phi\u1ebfu chi\u1ebfm 0,065% v\u1ed1n IMP.<\/p>\n<p>C\u00f9ng th\u1eddi gian v\u00e0 ph\u01b0\u01a1ng th\u1ee9c, K\u1ebf to\u00e1n tr\u01b0\u1edfng D\u01b0\u01a1ng Ho\u00e0ng V\u0169 \u0111\u00e3 b\u00e1n ra 12.000 c\u1ed5 phi\u1ebfu, qua \u0111\u00f3 gi\u1ea3m s\u1edf h\u1eefu v\u1ec1 c\u00f2n 10.000 c\u1ed5 phi\u1ebfu chi\u1ebfm 0,006% v\u1ed1n.<\/p>\n<p>D\u00e0n l\u00e3nh \u0111\u1ea1o Imexpharm tho\u00e1i v\u1ed1n trong b\u1ed1i c\u1ea3nh c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m n\u00e0y v\u1eeba \u0111\u1ed5i ch\u1ee7. Lian SGP Holding Pte. Ltd. b\u00e1o c\u00e1o \u0111\u00e3 mua v\u00e0o 104,5 tri\u1ec7u c\u1ed5 phi\u1ebfu IMP \u0111\u1ec3 n\u00e2ng s\u1edf h\u1eefu t\u1eeb 0% l\u00ean 67,87% v\u1ed1n \u0111i\u1ec1u l\u1ec7 v\u00e0 tr\u1edf th\u00e0nh c\u00f4ng ty m\u1eb9 c\u1ee7a Imexpharm.<\/p>\n<p>V\u1edbi gi\u00e1 ch\u00e0o mua 57.400 \u0111\u1ed3ng\/c\u1ed5 phi\u1ebfu, \u01b0\u1edbc t\u00ednh, Lian SGP Holding Pte. Ltd. \u0111\u00e3 chi ra g\u1ea7n 6.000 t\u1ef7 \u0111\u1ed3ng \u0111\u1ec3 th\u1ef1c hi\u1ec7n th\u01b0\u01a1ng v\u1ee5.<\/p>\n<p>Lian SGP Holding Pte. Ltd. l\u00e0 c\u00f4ng ty con gi\u00e1n ti\u1ebfp do &#8220;\u00f4ng l\u1edbn&#8221; d\u01b0\u1ee3c ph\u1ea9m Livzon Pharmaceutical Group (Trung Qu\u1ed1c) s\u1edf h\u1eefu 100%.<\/p>\n<p>Livzon Pharmaceutical Group l\u00e0 t\u1eadp \u0111o\u00e0n d\u01b0\u1ee3c ph\u1ea9m l\u1edbn c\u1ee7a Trung Qu\u1ed1c, \u0111\u01b0\u1ee3c th\u00e0nh l\u1eadp t\u1eeb n\u0103m 1985, v\u1ed1n \u0111i\u1ec1u l\u1ec7 hi\u1ec7n t\u1ea1i h\u01a1n 935 tri\u1ec7u Nh\u00e2n d\u00e2n t\u1ec7. T\u1eadp \u0111o\u00e0n chuy\u00ean nghi\u00ean c\u1ee9u, s\u1ea3n xu\u1ea5t, ph\u00e1t tri\u1ec3n c\u00e1c lo\u1ea1i d\u01b0\u1ee3c ph\u1ea9m, t\u00e2n d\u01b0\u1ee3c, \u0111\u00f4ng y, nguy\u00ean li\u1ec7u thu\u1ed1c\u2026 ho\u1ea1t \u0111\u1ed9ng tr\u00ean h\u01a1n 30 qu\u1ed1c gia to\u00e0n c\u1ea7u, trong \u0111\u00f3 c\u00f3 M\u1ef9, EU, H\u00e0n Qu\u1ed1c, Nh\u1eadt B\u1ea3n, khu v\u1ef1c \u0110\u00f4ng Nam \u00c1&#8230; Livzon Pharmaceutical Group hi\u1ec7n n\u1eb1m trong nh\u00f3m 25 doanh nghi\u1ec7p d\u01b0\u1ee3c l\u1edbn nh\u1ea5t Trung Qu\u1ed1c.<\/p>\n<p>Lian SGP Holding Pte. Ltd. nh\u1eadn chuy\u1ec3n nh\u01b0\u1ee3ng c\u1ed5 ph\u1ea7n Imexpharm t\u1eeb nh\u00f3m SK Group. Trong \u0111\u00f3, SK Investment Vina III Pte. Ltd \u0111\u00e3 b\u00e1n 68,8 tri\u1ec7u c\u1ed5 phi\u1ebfu, d\u1ef1 ki\u1ebfn h\u1ea1 t\u1ef7 l\u1ec7 n\u1eafm gi\u1eef t\u1eeb 47,69% xu\u1ed1ng c\u00f2n 4,6 tri\u1ec7u c\u1ed5 phi\u1ebfu, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng 3%.<\/p>\n<p>CTCP \u0110\u1ea7u t\u01b0 B\u00ecnh Minh Kim \u0111\u00e3 b\u00e1n to\u00e0n b\u1ed9 15,02 tri\u1ec7u c\u1ed5 phi\u1ebfu, qua \u0111\u00f3 kh\u00f4ng c\u00f2n n\u1eafm gi\u1eef c\u1ed5 phi\u1ebfu IMP n\u00e0o. V\u00e0 CTCP \u0110\u1ea7u t\u01b0 KBA c\u0169ng b\u00e1n ra to\u00e0n b\u1ed9 11,3 tri\u1ec7u c\u1ed5 phi\u1ebfu IMP \u0111ang n\u1eafm gi\u1eef \u0111\u1ec3 kh\u00f4ng c\u00f2n s\u1edf h\u1eefu c\u1ed5 phi\u1ebfu IMP n\u00e0o.<\/p>\n<p>C\u00e1c giao d\u1ecbch c\u1ee7a nh\u00f3m SK Group \u0111\u01b0\u1ee3c th\u1ef1c hi\u1ec7n trong th\u1eddi gian t\u1eeb 17-21\/4\/2026.<\/p>\n<\/p><\/div>","protected":false},"excerpt":{"rendered":"<p>Nhi\u1ec1u l\u00e3nh \u0111\u1ea1o c\u1ee7a C\u00f4ng ty c\u1ed5 ph\u1ea7n D\u01b0\u1ee3c ph\u1ea9m Imexpharm (IMP, s\u00e0n HoSE) v\u1eeba b\u00e1o c\u00e1o k\u1ebft qu\u1ea3 b\u00e1n [&hellip;]<\/p>","protected":false},"author":5,"featured_media":79347,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[221],"tags":[],"class_list":["post-79346","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-chung-khoan"],"acf":[],"_links":{"self":[{"href":"https:\/\/hbbgroup.net\/zh\/wp-json\/wp\/v2\/posts\/79346","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/hbbgroup.net\/zh\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/hbbgroup.net\/zh\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/hbbgroup.net\/zh\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/hbbgroup.net\/zh\/wp-json\/wp\/v2\/comments?post=79346"}],"version-history":[{"count":0,"href":"https:\/\/hbbgroup.net\/zh\/wp-json\/wp\/v2\/posts\/79346\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/hbbgroup.net\/zh\/wp-json\/wp\/v2\/media\/79347"}],"wp:attachment":[{"href":"https:\/\/hbbgroup.net\/zh\/wp-json\/wp\/v2\/media?parent=79346"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/hbbgroup.net\/zh\/wp-json\/wp\/v2\/categories?post=79346"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/hbbgroup.net\/zh\/wp-json\/wp\/v2\/tags?post=79346"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}